text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

D-HPBMC - Diseased Human Peripherial Blood Mononuclear Cells (Psoriasis)

Catalog #: 00219738
Limited Edition Peripherial Blood Mononuclear from Psoriasis Donor

Product Overview

Psoriasis is believed to be an immune related condition characterized by patches of abnormal skin. Psoriasis is chronic, lasting years or even an entire lifetime, and impacts millions of individuals every year. Psoriasis is believed to have a genetic component, however, scientists are still uncertain what specifically causes the disease. For individuals with psoriasis, skin cells grow at an abnormal rate causing the build-up of lesion sites. These flair-ups are often initiated by a trigger such as stress or injury. Lonza offers dermal fibroblasts, isolated from both lesion sites and non-lesion sites, all isolated from the same donor diagnosed with psoriasis.


  • Catalog no. 219739 (Lot no. 5F3028)
  • Donor Information: 30 year old Caucasian female
  • Culture Media: Lonza LGM-3TM Lymphocyte Growth Medium (Lonza Cat. No. CC-3211) + appropriate cytokines for serum free conditions
  • Culture Conditions: Culture following Lonza's Standard Protocol for culturing Peripheral Blood Mononuclear Cells
  • Quality Control Testing: Cell Count (57.8 million cells/vial), Viability (78%), HIV/HBV/HCV/Mycoplasma (not detected), Sterility (negative)

This product is classified as a Limited Edition Cell Type. Lonza CellBio Services occasionally obtains excess or additional cells from custom isolations that can be offered as individual cryopreserved vials. These Limited Edition Cells are available in limited inventory and may not be available again after inventory is depleted.

Content & Storage


1 x Cryopreserved Ampule with ≥50,000,000 cells/vial

Store at -180 C

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.